Clarus Therapeutics Holdings
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Clarus Therapeutics Holdings's balance sheet done over the years? Its assets were worth $51,708,000 last year, which is less than in the previous period. 131% of Clarus Therapeutics Holdings’s total assets is currently financed by debt. Its liabilities reached the amount of $67,627,000, which means an increase by 253% compared compared to last year.

Debt to Assets

Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT): Debt to assets
2020 59473560 19.13M 32.17%
2021 51708000 67.62M 130.79%

CRXT Balance Sheet (2020 – 2021)

2021 2020
Assets
Current assets:
Cash and cash equivalents
26.41M655.37K
Short term investments
058.65M
Net receivables
6.34M0
Inventory
14.21M0
Other current assets
4.67M-58.48M
Total current assets
51.64M823.51K
Non-current assets:
Property, Plant and Equipment
65K0
Goodwill
00
Intangible assets
00
Long term investments
00
Other non-current assets
058.65M
Total non-current assets
65K58.65M
Total assets
51.70M59.47M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
1.58M0
Short term debt
42.26M0
Total current liabilities
66.06M420.84K
Non-current liabilities:
Long term debt
00
Deferred tax
00
Other non-current liabilities
1.56M18.71M
Total non-current liabilities
1.56M18.71M
Total liabilities
67.62M19.13M
Data sourceData source